Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

10.5%

2 terminated/withdrawn out of 19 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

37%

7 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A
5(31.3%)
Phase 4
4(25.0%)
Phase 3
3(18.8%)
Phase 2
2(12.5%)
Phase 1
2(12.5%)
16Total
N/A(5)
Phase 4(4)
Phase 3(3)
Phase 2(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT05137119Phase 4Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial

Role: collaborator

NCT07270029Not ApplicableRecruiting

Sensory Toys for Anxiety Reduction - Can Fidget Toys Improve Stress and Help Children to Cope Before Surgery (STARFISH)

Role: lead

NCT06148025Phase 4Recruiting

Antibiotics and Vaccine Immune Responses Study

Role: collaborator

NCT07204990Not ApplicableNot Yet Recruiting

BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia

Role: lead

NCT07000877Phase 4Recruiting

Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.

Role: lead

NCT06354699Recruiting

A Longitudinal Study Looking at the Prevalence, Risk Factors & Consequences of Persistent Post-surgical Pain in Children

Role: lead

NCT05934318Not ApplicableRecruiting

L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)

Role: collaborator

NCT06002243Not ApplicableNot Yet Recruiting

Non-Expert Acquisition & Remote Expert Review of Screening Echocardiography Images From Child Health & AnteNatal Clinics

Role: collaborator

NCT02941107Phase 4Active Not Recruiting

Optimising Rotavirus Vaccine in Aboriginal Children

Role: lead

NCT02165813Phase 2Terminated

Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children

Role: lead

NCT04742842Phase 1Completed

The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers

Role: collaborator

NCT04496245Phase 3Completed

Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85

Role: collaborator

NCT01270074Phase 3Completed

Prevention of Bronchiectasis in Infants With Cystic Fibrosis

Role: collaborator

NCT04552379Phase 3Completed

The Containing Coronavirus Disease 19 (COVID-19) Trial

Role: collaborator

NCT02490007Completed

Pertussis Immunisation and Food Allergy

Role: lead

NCT03361163Phase 1Completed

Controlled Human Infection for Vaccination Against Streptococcus Pyogenes

Role: collaborator

NCT04167059Not ApplicableUnknown

Telehealth Support to Increase Physical Activity in Rett Syndrome

Role: lead

NCT04183322Completed

PCV13 in Non-pregnant Papua New Guinean Women

Role: lead

NCT02452905Phase 2Withdrawn

Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments

Role: lead

All 19 trials loaded